1. Pharmaxis
2. Home
3. About Us

About Us

Pharmaxis is a specialty pharmaceutical company involved in the research, development and commercialisation of new therapies for undertreated respiratory diseases.

Our first product, Aridol, is now registered for sale in the United States, Europe, Australia and South East Asia. Aridol is designed to assist in the management of both asthma and chronic obstructive pulmonary disease.

Our second product, Bronchitol, has completed the two regulatory Phase 3 trials in cystic fibrosis and  is part way through a second regulatory trial in bronchiectasis.

We are committed to bringing our therapeutic advances for respiratory and immune diseases to patients throughout the world, and to building an internationally successful pharmaceutical business: one that's built to last.

Company overview